Ventas (NYSE:VTR) Stock Price Expected to Rise, Mizuho Analyst Says

Ventas (NYSE:VTR) had its price objective raised by stock analysts at Mizuho from $87.00 to $94.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Mizuho’s target price would suggest a potential upside of 10.63% from the company’s previous close.

Other equities research analysts also recently issued reports about the stock. Wells Fargo & Company upped their price objective on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Morgan Stanley set a $90.00 target price on Ventas in a report on Friday, February 13th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $93.00 price target on shares of Ventas in a research report on Monday, February 9th. Argus set a $88.00 price target on Ventas in a report on Tuesday, February 10th. Finally, Scotiabank upped their price objective on Ventas from $80.00 to $93.00 and gave the company a “sector perform” rating in a research note on Monday. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $89.00.

Ventas Trading Down 2.1%

Shares of Ventas stock opened at $84.97 on Wednesday. The company has a market capitalization of $40.36 billion, a P/E ratio of 157.35, a price-to-earnings-growth ratio of 2.12 and a beta of 0.73. The stock has a fifty day simple moving average of $80.55 and a 200 day simple moving average of $75.58. Ventas has a 12-month low of $60.15 and a 12-month high of $87.87. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The company had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter last year, the business posted $0.81 earnings per share. Ventas’s revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, sell-side analysts anticipate that Ventas will post 3.4 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the sale, the chief executive officer directly owned 1,114,034 shares in the company, valued at $86,515,880.44. The trade was a 0.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Robert F. Probst sold 29,930 shares of the company’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the transaction, the chief financial officer directly owned 138,434 shares in the company, valued at $10,694,026.50. This represents a 17.78% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 86,106 shares of company stock valued at $6,931,397 over the last ninety days. 0.80% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Ventas

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bridgewater Advisors Inc. lifted its stake in shares of Ventas by 2.0% during the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock valued at $525,000 after buying an additional 133 shares in the last quarter. Arbor Capital Management Inc. ADV grew its stake in Ventas by 0.6% in the 3rd quarter. Arbor Capital Management Inc. ADV now owns 21,716 shares of the real estate investment trust’s stock valued at $1,520,000 after buying an additional 137 shares in the last quarter. IHT Wealth Management LLC raised its holdings in Ventas by 3.2% during the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after acquiring an additional 137 shares during the period. True Wealth Design LLC lifted its position in shares of Ventas by 32.0% during the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock worth $44,000 after acquiring an additional 138 shares in the last quarter. Finally, Cigna Investments Inc. New boosted its holdings in shares of Ventas by 3.3% in the fourth quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock worth $341,000 after acquiring an additional 142 shares during the period. Institutional investors own 94.18% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.